---
figid: PMC3260001__oncotarget-02-833-g001
figtitle: Abrogation of PIK3CA or PIK3R1 reduces proliferation, migration, and invasion
  in glioblastoma multiforme cells
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC3260001
filename: oncotarget-02-833-g001.jpg
figlink: /pmc/articles/PMC3260001/figure/F1/
number: F1
caption: Upon activation at the plasma membrane, the catalytic subunit of class IA
  PI3Ks phosphorylates phosphatidylinositol 4,5-bisphosphate (PIP2), converting it
  to phosphatidylinositol 3,4,5-triphosphate (PIP3). This results in the activation
  of several downstream pathways, including the Akt and mTOR pathways, which leads
  to increased proliferation and survival. PTEN activity converts PIP3 to PIP2. Interestingly,
  the p85α regulatory subunit has been shown to bind PTEN directly and enhance its
  lipid phosphatase activity []. This subunit may also be involved in the activation
  of migration and invasion-promoting pathways, possibly through the activation of
  small GTPases such as Cdc42 and Rac [, ]. p85α may interact with caspase 8 (in a
  non-apoptotic function of this caspase) to increase cell motility and Rac activation
  []. p85α has also been shown to interact with FAK, and this interaction correlates
  with FAK activation [].
papertitle: Abrogation of PIK3CA or PIK3R1 reduces proliferation, migration, and invasion
  in glioblastoma multiforme cells.
reftext: Genevieve L. Weber, et al. Oncotarget. 2011 Nov;2(11):833-849.
year: '2011'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9354339
figid_alias: PMC3260001__F1
figtype: Figure
redirect_from: /figures/PMC3260001__F1
ndex: d171c89d-dec5-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3260001__oncotarget-02-833-g001.html
  '@type': Dataset
  description: Upon activation at the plasma membrane, the catalytic subunit of class
    IA PI3Ks phosphorylates phosphatidylinositol 4,5-bisphosphate (PIP2), converting
    it to phosphatidylinositol 3,4,5-triphosphate (PIP3). This results in the activation
    of several downstream pathways, including the Akt and mTOR pathways, which leads
    to increased proliferation and survival. PTEN activity converts PIP3 to PIP2.
    Interestingly, the p85α regulatory subunit has been shown to bind PTEN directly
    and enhance its lipid phosphatase activity []. This subunit may also be involved
    in the activation of migration and invasion-promoting pathways, possibly through
    the activation of small GTPases such as Cdc42 and Rac [, ]. p85α may interact
    with caspase 8 (in a non-apoptotic function of this caspase) to increase cell
    motility and Rac activation []. p85α has also been shown to interact with FAK,
    and this interaction correlates with FAK activation [].
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - scb
  - LanB1
  - LanA
  - LanB2
  - Src42A
  - Csk
  - Src64B
  - Fak
  - Sos
  - drk
  - Cdc42
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - rab
  - Rab5
  - rho
  - Bx
  - Rho1
  - Lcp65Ab1
  - Rac1
  - Rac2
  - Akt
  - Mtl
  - Pten
  - ras
  - Ras64B
  - Ras85D
  - vap
  - Raf
  - Pdk1
  - Dsor1
  - Rok
  - rl
  - Pvf1
  - Pvf2
  - Pvf3
  - Pvr
  - Mtor
  - Tor
  - Act5C
  - Act42A
  - Act57B
  - Act79B
  - Act88F
  - Act87E
  - p53
  - betaTub60D
  - hth
  - List
  - pat
  - ptc
  - ITGA1
  - ITGA10
  - ITGA11
  - ITGA2
  - ITGA2B
  - ITGA3
  - ITGA4
  - ITGA5
  - ITGA6
  - ITGA7
  - ITGA8
  - ITGA9
  - ITGAD
  - ITGAE
  - ITGAL
  - ITGAM
  - ITGAV
  - ITGAX
  - ITGB1
  - ITGB2
  - ITGB3
  - ITGB4
  - ITGB5
  - ITGB6
  - ITGB7
  - ITGB8
  - ITGBL1
  - PIK3R1
  - PIK3CA
  - SRC
  - FGR
  - FYN
  - YES1
  - PTK2
  - XYLT2
  - SOS1
  - SOS2
  - GRB2
  - CDC42
  - AGFG1
  - RAB10
  - RAB11A
  - RAB11B
  - RAB12
  - RAB13
  - RAB14
  - RAB15
  - RAB17
  - RAB18
  - RAB19
  - RAB1A
  - RAB1B
  - RAB1C
  - RAB20
  - RAB21
  - RAB22A
  - RAB23
  - RAB24
  - RAB25
  - RAB26
  - RAB27A
  - RAB27B
  - RAB28
  - RAB2A
  - RAB2B
  - RAB30
  - RAB31
  - RAB32
  - RAB33A
  - RAB33B
  - RAB34
  - RAB35
  - RAB36
  - RAB37
  - RAB38
  - RAB39A
  - RAB39B
  - RAB3A
  - RAB3B
  - RAB3C
  - RAB3D
  - RAB40A
  - RAB40AL
  - RAB40B
  - RAB40C
  - RAB41
  - RAB42
  - RAB43
  - RAB44
  - RAB4A
  - RAB4B
  - RAB5A
  - RAB5B
  - RAB5C
  - RAB6A
  - RAB6B
  - RAB6C
  - RAB7A
  - RAB7B
  - RAB29
  - RAB8A
  - RAB8B
  - RAB9A
  - RAB9B
  - RABL2A
  - RABL2B
  - RABL3
  - IFT22
  - RHO
  - RHOD
  - RHOA
  - RHOB
  - RHOC
  - AKT1
  - RAC1
  - RAC2
  - RAC3
  - RHOG
  - PTEN
  - ARHGAP35
  - KRAS
  - HRAS
  - NRAS
  - RASA1
  - ARHGEF28
  - CASP8
  - CPN2
  - CYP11B2
  - CPNE2
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - PDK1
  - PDPK1
  - MAP2K1
  - MAP2K2
  - ROCK1
  - AKT2
  - AKT3
  - MAPK3
  - MAPK1
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - MTOR
  - MDM2
  - ACTA1
  - ACTA2
  - ACTB
  - ACTC1
  - ACTG1
  - ACTG2
  - TP53
  - TP63
  - TP73
  - Tyr
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Melanoma
  - Noonan syndrome
---
